# Bionano to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call Webcast on March 23, 2026
Canonical URL: https://biopharmsignal.com/news/BNGO/bionano-to-report-fourth-quarter-and-full-year-2025-financial-results-and-host-a-conference-call-webcast-on-march-23-2026
Ticker: BNGO
Company: BioNano Genomics
Source: BioNano Genomics
Published: 2026-03-09 20:05 EST
Original Source URL: https://ir.bionanogenomics.com
## Summary

SAN DIEGO, March 09, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Monday, March 23, 2026, at 4:30 p.m. Eastern Time to report financial results for the fourth quarter and full year 2025 and to highlight recent

## Article Body
SAN DIEGO, March 09, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Monday, March 23, 2026, at 4:30 p.m. Eastern Time to report financial results for the fourth quarter and full year 2025 and to highlight recent
## Recent Company News
- 2026-06-24 12:30 EST — [Bionano Announces Hiring of Chief Scientific Officer](https://biopharmsignal.com/news/BNGO/bionano-announces-hiring-of-chief-scientific-officer-8e8bfe70) — Source: BioNano Genomics
- 2026-06-18 12:00 EST — [Bionano Announces 67% Year-Over-Year Growth in Studies Featuring Optical Genome Mapping at ESHG 2026, Reflecting Expanding Global Adoption](https://biopharmsignal.com/news/BNGO/bionano-announces-67-year-over-year-growth-in-studies-featuring-optical-genome-m-7d9e22b4) — Source: BioNano Genomics
- 2026-06-11 12:00 EST — [Bionano Announces Multiple Publications in 2026 Describing Unique Utility of OGM in Studies of Reproductive Health and Prenatal Genetic Disorders](https://biopharmsignal.com/news/BNGO/bionano-announces-multiple-publications-in-2026-describing-unique-utility-of-ogm-3d3adb94) — Source: BioNano Genomics
- 2026-05-28 12:00 EST — [Bionano Announces Full Retirement of Outstanding Senior Secured Convertible Debentures](https://biopharmsignal.com/news/BNGO/bionano-announces-full-retirement-of-outstanding-senior-secured-convertible-debentures) — Source: BioNano Genomics
- 2026-05-26 12:00 EST — [Bionano Announces Largest OGM Study of T-Cell Acute Lymphoblastic Leukemia](https://biopharmsignal.com/news/BNGO/bionano-announces-largest-ogm-study-of-t-cell-acute-lymphoblastic-leukemia) — Source: BioNano Genomics
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)